Evidence map›Paper›PMID 26373733›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.

Ming Xiao, Yi Tang, Wen-Wen Chen, Ya-Lan Wang, Lian Yang, Xian Li, Guang-Lin Song, Jing Kuang

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.International journal of molecular sciences · 2019
    Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ming XiaoDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Yi TangDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Wen-Wen ChenDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Ya-Lan WangDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China. wangyalan074@126.com.
Lian YangDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Xian LiDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Guang-Lin SongDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Jing KuangDepartment of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, No. 1 Yixueyuan Rd, Chongqing, 400016, China.
Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The influence of the most important classical mono-ADP-ribosyltransferase, arginine ADP-ribosyltransferase 1 (Art1), on survival and apoptosis of colon carcinoma cells and the potential mechanisms have been partly discussed in our previous study but still need to be further studied. In this present study, Art1 of colon carcinoma CT26 cells was silenced with lentiviral vector-mediated short hairpin RNA (shRNA) or overexpressed with lentiviral vector-mediated complementary DNA (cDNA) and allograft transplant tumors are established in Balb/c mice. We verified Art1 knockdown increases apoptosis of CT26 cells transplant tumor; Art1 overexpression acts oppositely. Accordingly, growth of transplant tumors is inhibited in Art1 knockdown transplant tumors and increases in Art1 overexpression transplant tumors. Furthermore, activity of Akt and Erk cell signal pathways and expression of an apoptosis biomarker, βIII-tubulin (Tubb3), decrease when Art1 was silenced and increase when Art1 was overexpressed. Inhibiting Akt pathway or Erk pathway both downregulates expression of Tubb3 on protein and messenger RNA (mRNA) level, indicating that Tubb3 could be regulated by both Akt and Erk pathways, and plays a role in the influence of Art1 on apoptosis of Balb/c mice allograft transplant tumor. We also demonstrated that Bcl-2 family is not the responsible downstream factor of the Erk pathway in colon carcinoma cells which is undergoing apoptosis. These findings enrich the molecular mechanism for the function of Art1 in colon carcinoma and provide a complementary support for Art1 to be a potential therapeutic target of the treatment of this kind of malignant tumor.

Indexed as

ADP Ribose TransferasesAnimalsApoptosisBiomarkers, TumorCell Line, TumorColonColonic NeoplasmsDown-RegulationFemaleMAP Kinase Signaling SystemMiceMice, Inbred BALB CProto-Oncogene Proteins c-aktRNA, Small InterferingSignal TransductionTubulinADP Ribose TransferasesBiomarkers, TumorProto-Oncogene Proteins c-aktRNA, Small InterferingTubb3 protein, mouseTubulinAktApoptosisArt1ErkTubb3

Identifiers

PMID26373733
OpenAlexW1900821731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.